查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1641742

全球药物滥用检测市场按产品/服务、样本类型和最终用户划分 - 机会分析和产业预测（2024-2033 年）

Drug Abuse Testing Market By Product and Service , By Sample type By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年全球药物滥用检测市场规模为 500 万美元，预计到 2033 年将达到 880 万美元，2024 年至 2033 年的复合年增长率为 6%。

药物滥用检测市场-IMG1

药物滥用测试是指辨识人体内是否有非法药物、处方药或其代谢物的科学过程。这些测试是对尿液、血液、唾液、头髮或汗水等生物检体进行的，以确定个人是否使用了特定物质。药物滥用测试是职场安全、临床诊断、法律调查和康復计划的重要工具。

全球药物滥用障碍的惊人成长是药物滥用测试市场的主要驱动力。联合国毒品犯罪防制署（UNODC）的一份报告估计，到 2022 年，将有超过 2.84 亿 15 至 64 岁的人至少使用过一次毒品，这凸显了进行广泛检测的必要性。此外，人们越来越意识到药物滥用（例如酒后驾驶和毒品犯罪）对公共安全的影响，这也推动了执法和交通监控计画中定期进行药物测试的需求。此外，全球药品供应的增加也大大促进了市场的成长。例如，欧洲毒品和毒瘾监测中心 (EMCDDA) 预测，到 2024 年，欧洲各种毒品的供应将比以往任何时候都要充足，其中大麻是最常用的非法毒品，其次是可卡因。 。此外，经济高效且易于使用的家用药物检测套组的普及，也使个人和家庭对其的采用越来越广泛，从而促进了市场的扩大。然而，液相层析法质谱等先进的药物检测技术价格昂贵。这可能会限制采用，尤其是在资源受限的医疗保健环境中。对社会评判和歧视的恐惧可能会阻止个人自愿接受药物测试，从而进一步影响测试项目的发展。相反，即时检测设备、改进的免疫检测和质谱技术等技术创新正在使药物检测更加准确、快速和易于实现。预计这些发展将为预测期内全球市场的扩张提供有利可图的机会。

药物滥用测试市场分为产品/服务、样本类型、最终用户和地区。根据产品/服务，市场细分为分析仪器、快速测试设备、消耗品和化验服务。分析仪器又分为免疫检测分析仪、层析法分析仪、呼气分析仪等。快速检测设备细分为尿液检查设备及口腔液体检测设备。消耗品部分进一步分为检测试剂套件、样本收集杯、校准器和控制器以及其他。依样本类型，分为尿液、口腔液、呼吸、头髮和其他样本。根据最终用户，市场分为职场/学校、刑事司法系统/执法部门、实验室和医院。按地区分析，涵盖北美、欧洲、亚太地区、拉丁美洲、中东和非洲。

主要发现

按产品/服务划分，分析仪器在 2023 年占据了市场占有率。

根据样本类型，预计尿液部分将在 2023 年达到最高成长。

根据最终用户，职场和学校部门在 2023 年占据最大份额。

根据地区，预计北美将在 2023 年占据最大的市场占有率，并且预计在预测期内将以高速成长。

本报告可提供客製化（请联络销售人员以了解其他费用和时间表）

  • 监管指南
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析：市场规模和预测
  • 平均售价分析/价格点分析
  • 交叉細項分析：市场规模与预测
  • 扩展公司简介列表
  • 历史市场资料
  • Excel 格式的主要企业详细资料（包括位置、联络资讯、供应商/供应商网路等）

目录

第 1 章 简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 主要投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会

4. 药物滥用检测市场（依产品和服务）

  • 市场概况
  • 分析设备
    • 免疫检测分析仪
    • 层析法分析设备
    • 呼吸分析仪
  • 快速检测装置
    • 尿液检查设备
    • 口腔液体检测装置
  • 耗材
    • 检测套件
    • 样品收集杯
    • 校准器控制
    • 其他的
  • 化验服务

5. 药物滥用检测市场（依样本类型）

  • 市场概况
  • 尿
  • 口腔液体
  • 吐气
  • 头髮
  • 其他范例

6. 药物滥用检测市场（依最终用户划分）

  • 市场概况
  • 职场/学校
  • 刑事司法系统与执法
  • 实验室
  • 医院

7. 药物滥用检测市场（按地区）

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国药物滥用检测市场
    • 加拿大药物滥用检测市场
    • 墨西哥药物滥用检测市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国药物滥用检测市场
    • 德国药物滥用检测市场
    • 义大利药物滥用检测市场
    • 西班牙药物滥用检测市场
    • 英国药物滥用检测市场
    • 其他欧洲国家药物滥用检测市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国的药物滥用检测市场
    • 日本药物滥用检测市场
    • 印度药物滥用检测市场
    • 韩国药物滥用检测市场
    • 澳洲药物滥用检测市场
    • 其他亚太地区药物滥用检测市场
  • 拉丁美洲、中东和非洲
    • 主要市场趋势和机会
    • 巴西药物滥用检测市场
    • 南非药物滥用检测市场
    • 沙乌地阿拉伯药物滥用检测市场
    • 其他拉丁美洲、中东和非洲药物滥用检测市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 前 10 家公司的产品映射
  • 竞争仪錶板
  • 竞争热图
  • 主要企业的定位：2023年

第九章 公司简介

  • The Dragerwerk AG And Co. KGaA
  • Abbott Laboratories
  • F. HOFFMANN-LA ROCHE AG
  • Bio Rad Laboratories, Inc.
  • Siemens AG
  • Thermo Fisher Scientific, Inc.
  • Laboratory Corporation Of America Holdings
  • Danaher Corporation
  • Quest Diagnostics Incorporated
  • Express Diagnostics International Inc.
简介目录
Product Code: A00035

The drug abuse testing market was valued at $5.0 million in 2023, and is projected to reach $8.8 million by 2033, growing at a CAGR of 6% from 2024 to 2033.

Drug Abuse Testing Market - IMG1

Drug abuse testing refers to the scientific process of identifying the presence of illicit drugs, prescription medications, or their metabolites in a person's system. This testing is conducted using biological specimens such as urine, blood, saliva, hair, or sweat to determine if an individual has used specific substances. Drug abuse testing is a critical tool in workplace safety, clinical diagnostics, legal investigations, and rehabilitation programs.

Alarming increase in prevalence of substance abuse disorders worldwide is a primary driver of the drug abuse testing market. According to a report by the United Nations Office on Drugs and Crime (UNODC), over 284 million people aged 15-64 used drugs at least once in 2022, underscoring the need for widespread testing. In addition, rise in awareness about the impact of substance abuse on public safety, such as impaired driving and drug-related crimes, has driven the demand for routine drug testing in law enforcement and traffic monitoring programs. Moreover, increase in global drug availability significantly contributes toward the market growth. For instance, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) reported in 2024 that Europe is experiencing unprecedented availability of various drugs, with cannabis being the most commonly used illicit drug, followed by cocaine. Furthermore, the availability of cost-effective and easy-to-use home drug testing kits has seen increased adoption among individuals and families, contributing to market expansion. However, sophisticated drug testing techniques, such as liquid chromatography-mass spectrometry, are expensive. This can limit their adoption, especially in resource-constrained healthcare settings. Fear of societal judgment and discrimination may deter individuals from undergoing drug testing voluntarily, further affecting the growth of testing programs. On the contrary, technological innovations, such as point-of-care testing devices, improved immunoassays, and mass spectrometry techniques, have made drug testing more accurate, faster, and accessible. Such developments are expected to offer remunerative opportunities for the expansion of the global market during the forecast period.

The drug abuse testing market is segmented into product & service, sample type, end user, and region. By product & service, the market is divided into analyzers, rapid testing devices, consumables and laboratory services. The analyzers segment is further segmented into immunoassay analyzers, chromatography analyzers and breath analyzers. The rapid testing devices is subdivided into urine testing devices and oral fluid testing devices. The consumables segment is further categorized into assay kits, sample collection cups, calibrators & controls, and others. Depending on sample type, the market is segregated into urine, oral fluid, breath, hair, and other samples. By end user, it is fragmented into workplaces & schools, criminal justice systems & law enforcement agencies, research laboratories, and hospitals. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product & service, the analyzers segment dominated the market share in 2023.

On the basis of sample type, the urine segment exhibit the highest growth in 2023.

Depending on end user segment, the workplaces & schools segment garnered the largest share in 2023.

Region wise, North America held the largest market share in 2023, and is projected to grow at a high pace during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global drug abuse testing market include The Dragerwerk AG & Co. KGaA, Abbott Laboratories, F. HOFFMANN-LA ROCHE AG, Bio Rad Laboratories, Inc., Siemens AG, Thermo Fisher Scientific, Inc., Laboratory Corporation of America Holdings, Danaher Corporation, Quest Diagnostics Incorporated, and Express Diagnostics International Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Average Selling Price Analysis / Price Point Analysis
  • Criss-cross segment analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product And Service

  • Analyzers
    • Immunoassay analyzers
    • Chromatography analyzers
    • Breath analyzers
  • Rapid Testing Devices
    • Urine testing devices
    • Oral fluid testing devices
  • Consumables
    • Assay kits
    • Sample collection cups
    • Calibrators and controls
    • Others
  • Laboratory Services

By Sample Type

  • Urine
  • Oral Fluid
  • Breath
  • Hair
  • Other Samples

By End User

  • Workplaces and Schools
  • Criminal Justice Systems and Law Enforcement Agencies
  • Research laboratories
  • Hospitals

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • The Dragerwerk AG & Co. KGaA
    • Abbott Laboratories
    • F. HOFFMANN-LA ROCHE AG
    • Bio Rad Laboratories, Inc.
    • Siemens AG
    • Thermo Fisher Scientific, Inc.
    • Laboratory Corporation of America Holdings
    • Danaher Corporation
    • Quest Diagnostics Incorporated
    • Express Diagnostics International Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: DRUG ABUSE TESTING MARKET, BY PRODUCT AND SERVICE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product And Service
  • 4.2. Analyzers
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
    • 4.2.5. Immunoassay analyzers
      • 4.2.5.1. Market Size and Forecast
    • 4.2.6. Chromatography analyzers
      • 4.2.6.1. Market Size and Forecast
    • 4.2.7. Breath analyzers
      • 4.2.7.1. Market Size and Forecast
  • 4.3. Rapid Testing Devices
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
    • 4.3.5. Urine testing devices
      • 4.3.5.1. Market Size and Forecast
    • 4.3.6. Oral fluid testing devices
      • 4.3.6.1. Market Size and Forecast
  • 4.4. Consumables
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
    • 4.4.5. Assay kits
      • 4.4.5.1. Market Size and Forecast
    • 4.4.6. Sample collection cups
      • 4.4.6.1. Market Size and Forecast
    • 4.4.7. Calibrators and controls
      • 4.4.7.1. Market Size and Forecast
    • 4.4.8. Others
      • 4.4.8.1. Market Size and Forecast
  • 4.5. Laboratory Services
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country

CHAPTER 5: DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Sample Type
  • 5.2. Urine
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Oral Fluid
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Breath
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Hair
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country
  • 5.6. Other Samples
    • 5.6.1. Key Market Trends, Growth Factors and Opportunities
    • 5.6.2. Market Size and Forecast, By Region
    • 5.6.3. Market Share Analysis, By Country

CHAPTER 6: DRUG ABUSE TESTING MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Workplaces And Schools
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Criminal Justice Systems And Law Enforcement Agencies
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Research Laboratories
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Hospitals
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country

CHAPTER 7: DRUG ABUSE TESTING MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product And Service
    • 7.2.3. Market Size and Forecast, By Sample Type
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Drug Abuse Testing Market
      • 7.2.6.1. Market Size and Forecast, By Product And Service
      • 7.2.6.2. Market Size and Forecast, By Sample Type
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Drug Abuse Testing Market
      • 7.2.7.1. Market Size and Forecast, By Product And Service
      • 7.2.7.2. Market Size and Forecast, By Sample Type
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Drug Abuse Testing Market
      • 7.2.8.1. Market Size and Forecast, By Product And Service
      • 7.2.8.2. Market Size and Forecast, By Sample Type
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product And Service
    • 7.3.3. Market Size and Forecast, By Sample Type
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Drug Abuse Testing Market
      • 7.3.6.1. Market Size and Forecast, By Product And Service
      • 7.3.6.2. Market Size and Forecast, By Sample Type
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Drug Abuse Testing Market
      • 7.3.7.1. Market Size and Forecast, By Product And Service
      • 7.3.7.2. Market Size and Forecast, By Sample Type
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Drug Abuse Testing Market
      • 7.3.8.1. Market Size and Forecast, By Product And Service
      • 7.3.8.2. Market Size and Forecast, By Sample Type
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Drug Abuse Testing Market
      • 7.3.9.1. Market Size and Forecast, By Product And Service
      • 7.3.9.2. Market Size and Forecast, By Sample Type
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Drug Abuse Testing Market
      • 7.3.10.1. Market Size and Forecast, By Product And Service
      • 7.3.10.2. Market Size and Forecast, By Sample Type
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest Of Europe Drug Abuse Testing Market
      • 7.3.11.1. Market Size and Forecast, By Product And Service
      • 7.3.11.2. Market Size and Forecast, By Sample Type
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product And Service
    • 7.4.3. Market Size and Forecast, By Sample Type
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Drug Abuse Testing Market
      • 7.4.6.1. Market Size and Forecast, By Product And Service
      • 7.4.6.2. Market Size and Forecast, By Sample Type
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Drug Abuse Testing Market
      • 7.4.7.1. Market Size and Forecast, By Product And Service
      • 7.4.7.2. Market Size and Forecast, By Sample Type
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Drug Abuse Testing Market
      • 7.4.8.1. Market Size and Forecast, By Product And Service
      • 7.4.8.2. Market Size and Forecast, By Sample Type
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Drug Abuse Testing Market
      • 7.4.9.1. Market Size and Forecast, By Product And Service
      • 7.4.9.2. Market Size and Forecast, By Sample Type
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Drug Abuse Testing Market
      • 7.4.10.1. Market Size and Forecast, By Product And Service
      • 7.4.10.2. Market Size and Forecast, By Sample Type
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Drug Abuse Testing Market
      • 7.4.11.1. Market Size and Forecast, By Product And Service
      • 7.4.11.2. Market Size and Forecast, By Sample Type
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product And Service
    • 7.5.3. Market Size and Forecast, By Sample Type
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Drug Abuse Testing Market
      • 7.5.6.1. Market Size and Forecast, By Product And Service
      • 7.5.6.2. Market Size and Forecast, By Sample Type
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Drug Abuse Testing Market
      • 7.5.7.1. Market Size and Forecast, By Product And Service
      • 7.5.7.2. Market Size and Forecast, By Sample Type
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Drug Abuse Testing Market
      • 7.5.8.1. Market Size and Forecast, By Product And Service
      • 7.5.8.2. Market Size and Forecast, By Sample Type
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Drug Abuse Testing Market
      • 7.5.9.1. Market Size and Forecast, By Product And Service
      • 7.5.9.2. Market Size and Forecast, By Sample Type
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping Of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. The Dragerwerk AG And Co. KGaA
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Abbott Laboratories
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. F. HOFFMANN-LA ROCHE AG
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Bio Rad Laboratories, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Siemens AG
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Thermo Fisher Scientific, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Laboratory Corporation Of America Holdings
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Danaher Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Quest Diagnostics Incorporated
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Express Diagnostics International Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments